VERRICA PHARMACEUTICALS INC.
VRCA US92511W1080
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -24% | -71% | 154% | -90% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Hayes Christopher G. CLO |
0.65 USD |
4,315 Sold |
2,805 USD |
14/03/2025 | 17/03/2025 |
| Kohler Terry CFO |
2.46 USD |
7,899 Sold |
19,432 USD |
26/08/2024 | 27/08/2024 |
| Goldenberg Gary CMO |
2.46 USD |
3,601 Sold |
8,858 USD |
26/08/2024 | 27/08/2024 |
| White Ted CEO |
2.46 USD |
9,021 Sold |
22,192 USD |
26/08/2024 | 27/08/2024 |
| Hayes Christopher G. CLO |
2.46 USD |
9,530 Sold |
23,444 USD |
26/08/2024 | 27/08/2024 |
| Bonaccorso Joe CCO |
2.46 USD |
8,993 Sold |
22,123 USD |
26/08/2024 | 27/08/2024 |
| Bonaccorso Joe CCO |
2.66 USD |
24,709 Sold |
65,726 USD |
26/08/2024 | 26/08/2024 |
| White Ted CEO |
2.66 USD |
24,979 Sold |
66,444 USD |
26/08/2024 | 26/08/2024 |
| Goldenberg Gary CMO |
2.66 USD |
9,888 Sold |
26,302 USD |
26/08/2024 | 26/08/2024 |
| Kohler Terry CFO |
2.66 USD |
21,820 Sold |
58,041 USD |
26/08/2024 | 26/08/2024 |